280 GLP-1 Clinics in California (2026)

Not for weight loss on its own for members age 21 and older, as of January 1, 2026. On that date Medi-Cal removed Wegovy, Zepbound and Saxenda from its drug list for weight-loss use, and earlier approvals expired. Medi-Cal still covers GLP-1s such as Ozempic and Mounjaro for type 2 diabetes. Since April 1, 2026, Wegovy for noncirrhotic MASH (a liver condition) does not require an approved prior authorization, though claims must carry the right ICD-10-CM diagnosis code. Other diagnoses still require a prior authorization request, including Wegovy for cardiovascular disease and Zepbound for obstructive sleep apnea; a diagnosis alone does not guarantee approval. For members under 21, weight-loss requests are still reviewed for medical necessity under Medicaid's EPSDT benefit. Commercial plans set their own rules, so ask your insurer directly.

Source: DHCS Medi-Cal Rx bulletin, November 14, 2025 and Medi-Cal Rx bulletin, April 6, 2026

Sometimes. A patient-specific prescription alone does not establish that compounding is permitted. The FDA declared the tirzepatide shortage over in December 2024 and the semaglutide shortage over in February 2025. Since then, a state-licensed 503A pharmacy may not regularly make what is essentially a copy of an approved drug such as Wegovy, Zepbound, Ozempic or Mounjaro. One exception is when the prescriber determines and documents a change that produces a significant difference for that patient. Other federal and California compounding rules still apply on top of that. Ask the clinic to explain why a compounded version is permitted in your case.

Source: FDA compounding policy statement, updated April 1, 2026

There are 280 GLP-1 weight loss clinics across 78 cities in California. The most providers are in San Diego (45), San Francisco (38), San Jose (32). The average patient rating is 4.8 out of 5.

California clinics prescribe Semaglutide, Tirzepatide, Ozempic, Wegovy, Mounjaro, Zepbound. The most commonly offered are semaglutide (214 clinics), tirzepatide (174 clinics), ozempic (75 clinics), wegovy (62 clinics). Not all clinics list their full medication menu, so contact providers directly to confirm what they prescribe.

Yes. 111 of 280 clinics in California (40%) offer telehealth consultations.

Based on 63 California clinics that publish pricing, programs start from $59/month. The typical range is $149 to $299/month depending on medication type and included services. Brand-name prices without insurance depend on the drug, the dose and where you fill the prescription, and both drug makers now sell some doses directly to cash-paying patients for less than the list price. Compounded versions are not FDA-approved, and since the shortages ended compounding pharmacies generally may not make copies of these drugs, with narrow exceptions. Many telehealth clinics bundle medication and visits into one monthly fee.

Source: FDA compounding policy statement, updated April 1, 2026

San Diego leads California with 45 GLP-1 clinics. San Francisco (38) and San Jose (32) round out the top three. Across the state, 275 clinics offer in-person visits and 111 offer telehealth.